Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
BVT.115959
print preview
bookmark
share with colleague
General Information
Company
Swedish Orphan Biovitrum AB
Description
Adenosine A2A receptor agonist
Molecular Target
Adenosine A2A receptor (ADORA2A)
Mechanism of Action
Adenosine A2A receptor agonist
Latest Stage of Development
Phase II
Indication
Pain
Partner
CBT Development Ltd.
;
Ergomed Clinical Research Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy